1. Home
  2. MRSN vs AXIL Comparison

MRSN vs AXIL Comparison

Compare MRSN & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • AXIL
  • Stock Information
  • Founded
  • MRSN 2001
  • AXIL 2015
  • Country
  • MRSN United States
  • AXIL United States
  • Employees
  • MRSN N/A
  • AXIL N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • AXIL Package Goods/Cosmetics
  • Sector
  • MRSN Health Care
  • AXIL Consumer Discretionary
  • Exchange
  • MRSN Nasdaq
  • AXIL Nasdaq
  • Market Cap
  • MRSN 37.0M
  • AXIL 36.8M
  • IPO Year
  • MRSN 2017
  • AXIL N/A
  • Fundamental
  • Price
  • MRSN $8.07
  • AXIL $5.70
  • Analyst Decision
  • MRSN Strong Buy
  • AXIL
  • Analyst Count
  • MRSN 3
  • AXIL 0
  • Target Price
  • MRSN $33.00
  • AXIL N/A
  • AVG Volume (30 Days)
  • MRSN 41.5K
  • AXIL 22.6K
  • Earning Date
  • MRSN 11-12-2025
  • AXIL 10-07-2025
  • Dividend Yield
  • MRSN N/A
  • AXIL N/A
  • EPS Growth
  • MRSN N/A
  • AXIL N/A
  • EPS
  • MRSN N/A
  • AXIL 0.15
  • Revenue
  • MRSN $34,769,000.00
  • AXIL $27,262,468.00
  • Revenue This Year
  • MRSN N/A
  • AXIL N/A
  • Revenue Next Year
  • MRSN N/A
  • AXIL N/A
  • P/E Ratio
  • MRSN N/A
  • AXIL $56.50
  • Revenue Growth
  • MRSN 16.14
  • AXIL 0.07
  • 52 Week Low
  • MRSN $5.21
  • AXIL $3.54
  • 52 Week High
  • MRSN $70.75
  • AXIL $10.75
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 61.29
  • AXIL 43.15
  • Support Level
  • MRSN $7.63
  • AXIL $5.53
  • Resistance Level
  • MRSN $8.35
  • AXIL $6.26
  • Average True Range (ATR)
  • MRSN 0.39
  • AXIL 0.57
  • MACD
  • MRSN 0.01
  • AXIL -0.06
  • Stochastic Oscillator
  • MRSN 72.97
  • AXIL 8.43

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About AXIL AXIL Brands Inc. Common Stock

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.

Share on Social Networks: